Editas Medicine, Inc. (EDIT) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$40.5M

Net Income/Loss (FY2025)

-$160.1M

Total Assets (FY2025)

$186.5M

Total Equity (FY2025)

$27.3M

Cash Flows from Operating Activities (FY2025)

-$165.2M

Source: Editas Medicine, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.